The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer.

Bellardita, L., Valdagni, R., Van Den Bergh, R., Randsdorp, H., Repetto, C., Venderbos, L., Lane, J., Korfage, I., How does active surveillance for prostate cancer affect quality of life? A systematic review, <<EUROPEAN UROLOGY>>, 2015; 67 (4): 637-645. [doi:10.1016/j.eururo.2014.10.028] [http://hdl.handle.net/10807/68070]

How does active surveillance for prostate cancer affect quality of life? A systematic review

Repetto, Claudia;
2015

Abstract

The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer.
Inglese
Bellardita, L., Valdagni, R., Van Den Bergh, R., Randsdorp, H., Repetto, C., Venderbos, L., Lane, J., Korfage, I., How does active surveillance for prostate cancer affect quality of life? A systematic review, <>, 2015; 67 (4): 637-645. [doi:10.1016/j.eururo.2014.10.028] [http://hdl.handle.net/10807/68070]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/68070
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 89
  • ???jsp.display-item.citation.isi??? 92
social impact